Cell Line Development Market is expected to reach $3.96 billion by 2019 from$2.2 billion in 2014


Posted June 29, 2016 by Priyas

This report studies the global cell line development market for the forecast period of 2014 to 2019.This market is expected to reach $3.96 billion by 2019 from$2.2 billion in 2014, and is poised to grow at a CAGR of 12.5% from 2014 to 2019.

 
The “Cell Line Development Market by Product (Equipment, Media and Reagents), by Source, by type, by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019” analyzes and studies the major market drivers, threats, opportunities, and challenges.

Browse 114 market data tables and 64 figures spread through 225 pages and in-depth TOC on “Cell Line Development Market

http://www.marketsandmarkets.com/Market-Reports/cell-line-development-market-152900899.html

Early buyers will receive 10% customization on reports.

The global cell line development market is segmented on the basis of products, type of cell lines, source of cell lines, applications, and geographies.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=152900899

Based on products, the cell line development market is categorized into equipment, and media &reagents.The media and reagents segment is expected to account for a major share of the cell line development market, by product in 2014.

Bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery are the key application areas of cell lines. Bioproduction is expected to account for a major share among the application areas in the cell line development market.

Customization on this report @ http://www.marketsandmarkets.com/requestCustomization.asp?id=152900899

Over the years, the demand for cell line development equipment and media and reagents is likely to increase owing to the increasing demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies to develop cell lines. However, in spite of innovative technologies in the market, developing stable and authentic cell lines still remains a challenge. Increasing risk of pandemics and communicable diseases are expected to create opportunities for the development of cell lines.

Some of the major players in the global cell line development market include American Type Culture Collection (ATCC) (U.S.), Lonza Group AG (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.K.), Sigma-Aldrich Corporation (U.S.), Selexis SA (Switzerland), European Collection of Cell Cultures (ECACC) (U.K.), Corning, Inc. (U.S.), Wuxi App Tec, Inc. (China), and Sartorious AG (Germany).
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mr. Rohan
Phone 1-888-600-6441
Business Address UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India
Country India
Categories Health
Tags cell line development market
Last Updated June 29, 2016